SCHEMBL25916103

SCHEMBL25916103

Oc1cc(Cl)cc2cccc(-c3cccc(Br)c3F)c12

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ DNMT1 P26358 1/20 0.33
▸ CACNA1B Q00975 1/20 0.33
▸ APBA1 Q02410 1/20 0.33
▸ MCL1 Q07820 1/20 0.33
▸ APOBEC3G Q9HC16 1/20 0.33
▸ CXCR2 P25025 3/20 0.33
▸ PDK2 Q15119 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ CA7 P43166 1/20 0.32
▸ CA9 Q16790 1/20 0.32
▸ HPGD P15428 2/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PSD A5PKW4 1/20 0.31
▸ AMY1A P0DUB6 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21755999 0.81 CXCR2 (0.44) ALDH1A1MEN1KMT2ACXCR2PDK2
SCHEMBL24126569 0.78 AMY1A (0.36) MEN1KMT2ANPC1SMN1; SMN2AMY1A
SCHEMBL21995608 0.76 EPHX2 (0.41) ALDH1A1MEN1KMT2ACXCR2CA1
SCHEMBL20739878 0.75 AMY1A (0.42) ALDH1A1MEN1KMT2APSDAMY1A
SCHEMBL28672182 0.72 PDPK1 (0.38) ALDH1A1MEN1KMT2ACA9HPGD
SCHEMBL22884323 0.71 TSHR (0.39) ALDH1A1MEN1KMT2APDK2CA1
SCHEMBL29937317 0.71 MEN1 (0.39) ALDH1A1MEN1KMT2ADNMT1CACNA1B
SCHEMBL29344255 0.71 MEN1 (0.39) ALDH1A1MEN1KMT2ADNMT1CACNA1B
SCHEMBL25056599 0.71 MAOA (0.43) ALDH1A1MEN1KMT2APDK2CA1
SCHEMBL30604354 0.71 ALDH1A1 (0.41) ALDH1A1MEN1KMT2APDK2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-07-27 — — US disclosed
US-20230240134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-07-27 — — US disclosed
EP-4169912-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-04-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 ALDH1A1 9/4885MEN1 257/4885KMT2A 758/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback